GlassScriptPhysician profile
Jack A Pines
NPI 1285699447
$3,432.63
in general payments reported to CMS, 2019-2025
25 companies · $317 in 2025
The $317 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $579 · 2020: $184 · 2021: $302 · 2022: $415 · 2023: $1,502 · 2024: $135 · 2025: $317.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,402 · Travel and Lodging: $486 · Education: $65.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,401.83 |
| Travel and Lodging | $486.32 |
| Education | $65.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $821.81 | 2023 | Aquabeam Robotic System |
| Myriad Genetic Laboratories, INC. | $572.55 | 2021-2025 | Prolaris, Myrisk |
| Janssen Biotech, INC. | $360.51 | 2019-2025 | Erleada |
| Karl Storz Endoscopy-America | $330.00 | 2019 | |
| Astellas Pharma US INC | $268.06 | 2019-2023 | Myrbetriq |
| Pfizer INC. | $158.61 | 2021-2025 | |
| Abbott Laboratories | $130.54 | 2023-2025 | Proclaim |
| Olympus America INC. | $111.47 | 2021 | |
| Tempus Ai, INC | $100.45 | 2025 | Xt Cdx |
| Ferring Pharmaceuticals INC. | $90.49 | 2025 | Adstiladrin |
| Boston Scientific Corporation | $67.57 | 2019-2024 | Ams 700 |
| Antares Pharma, INC. | $51.17 | 2022-2023 | Nocdurna, Xyosted, Tlando |
| Tolmar, INC. | $45.58 | 2023-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $44.89 | 2023 | |
| Rochester Medical Corporation | $44.25 | 2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $37.22 | 2020 | |
| Ethicon US, LLC | $29.22 | 2019 | |
| Progenics Pharmaceuticals, INC. | $27.29 | 2023 | Pylarify |
| Blue Earth Diagnostics | $26.16 | 2020 | |
| Myovant Sciences INC. | $25.38 | 2022 | |
| Teleflex LLC | $19.48 | 2022 | |
| Coloplast Corp | $18.19 | 2020 | |
| Convatec INC. | $17.78 | 2019 | |
| Halozyme INC | $17.60 | 2023 | |
| Abbvie INC. | $16.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Pines listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.